This new antiretroviral with a unique mechanism of action may be lifesaving for those with treatment-resistant HIV infection.
T. Sam Albanesi, MD, MA
Advertisement
Albanesi is an infectious disease fellow at Temple University Hospital in Philadelphia, Pennsylvania with a special interest in caring for people living with HIV.
Articles by T. Sam Albanesi, MD, MA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Contagion Live
1
Oral Carbapenem Tebipenem HBr Demonstrates Non-Inferiority to IV Therapy in Phase III PIVOT-PO Trial
2
Introducing Cefiderocol Earlier in Difficult-to-Treat-Infections
3
Dynavax Presents Data for Shingles Vaccine, Launches Head-to-Head Study Against Shingrix
4
New Data Highlight Adult Pneumococcal Serotypes with Greater Antibiotic Resistance and Disease Burden Covered by Merck’s Vaccine
5
